Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Abstract Text:

Kazuo Nakamura,Sho-Ichi Yamagishi,Hisashi Adachi,Takanori Matsui,Yayoi Kurita-Nakamura,Masayoshi Takeuchi,Hiroyoshi Inoue,Tsutomu Imaizumi,

BACKGROUND: Atherosclerosis is an inflammatory disease. Monocyte chemoattractant protein-1 (MCP-1) is an essential chemokine responsible for the recruitment of monocytes to inflammatory lesions in the vasculature, an initial step of atherosclerosis. Since serum levels of MCP-1 are higher in patients with type 2 diabetes, inhibition of MCP-1 may be a novel therapeutic target for prevention of accelerated atherosclerosis in diabetes. However, little is known about the regulation and determinants of serum MCP-1 levels in patients with diabetes. In this study, we examined the determinants of serum MCP-1 levels in type 2 diabetic patients. METHODS: Eighty-six consecutive outpatients with type 2 diabetes (36 male and 50 female; mean age 68.4 +/- 9.6) underwent a complete history and physical examination, determination of blood chemistries, MCP-1, tumour necrosis factor-alpha, adiponectin, advanced glycation end products (AGEs), and soluble form of receptor for AGEs (sRAGE). We examined the association between MCP-1 levels and those in anthropometric, metabolic and inflammatory variables in these subjects. RESULTS: Univariate regression analysis showed that serum levels of MCP-1 were positively associated with AGEs (r = 0.386, p < 0.001) and sRAGE (r = 0.315, p < 0.001). After adjusting for age and sex, AGEs (p < 0.001) and sRAGE (p < 0.05) still remained significant. CONCLUSION: The results demonstrate for the first time that circulating levels of AGEs and sRAGE are independent determinants of serum MCP-1 levels in patients with type 2 diabetes. Our present observations suggest the AGEs-RAGE system may be mainly involved in the elevation of MCP-1 in type 2 diabetic patients. Copyright (c) 2007 John Wiley & Sons, Ltd.

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Publishing Authors By Initials

K Nakamura,S Yamagishi,H Adachi,T Matsui,Y Kurita-Nakamura,M Takeuchi,H Inoue,T Imaizumi,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Diabetes/metabolism research and reviews

VOLUME: 24

Page Numbers: 109-14

Journal Abbreviation: Diabetes Metab. Res. Rev.

ISSN: 1520-7552

DAY: 4

MONTH: Feb

YEAR: 2008

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100883450

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.

AFFILIATION: Department of Medicine, Kurume University School of Medicine, Kurume, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Diabetes Metab Res Rev

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Circulating advanced glycation end products AGEs and soluble form of receptor for AGEs sRAGE are independent determinants of serum monocyte chemoattractant protein-1 MCP-1 levels in patients with type 2 diabetes Related Publications

• A novel acetyl-CoA carboxylase inhibitor reduces de novo fatty acid synthesis in HepG2 cells and rat primary hepatocytes.
• Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
• Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications.
• Antiatherogenic effect of isoflavones in ovariectomized apolipoprotein e-deficient mice.
• Bilateral pseudocysts of the auricles.
• CORRELATION BETWEEN BRAIN CATECHOLAMINE AND SEDATIVE ACTION OF RESERPINE.
• Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
• Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
• Colorectal polypectomy and risk of colorectal cancer by subsite: the Fukuoka Colorectal Cancer study.
• Detection of coronary artery stenosis after successful percutaneous coronary intervention by dipyridamole stress portable type signal-averaged electrocardiography: a prospective study.
• Effects of milk fermented byLactobacillus gasseri SBT2055 on adipocyte size in rats.
• FKF1 and GIGANTEA complex formation is required for day-length measurement in Arabidopsis.
• Inhibitors of Advanced Glycation End Products (AGEs): Potential Utility for the Treatment of Cardiovascular Disease.
• LXR Agonist Increases the Lymph HDL Transport in Rats by Promoting Reciprocally Intestinal ABCA1 and apo A-I mRNA Levels.
• Lumbosacral subdural hematoma following a ruptured aneurysmal subarachnoid hemorrhage.
• Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
• Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
• Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
• Oxidative stress is related to exercise intolerance in patients with heart failure.
• PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
• Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: A possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
• Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication.
• Reply to Letter Regarding Article, "Effect of Autologous Bone-marrow Cell Transplantation on Ischemic Ulcer in Patients With Buerger's Disease".
• Serum Level of Advanced Glycation End-Products (AGEs) is an Independent Determinant of Plasminogen Activator Inhibitor-1 (PAI-1) in Nondiabetic General Population.
• Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.
• The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
• The properties of ATPase of synaptic vesicle fraction.
• Vitamin C reversed malfunction of peripheral blood-derived mononuclear cells in smokers through antioxidant properties.
• [Internal secretion and hypertension. Catecholamine metabolism and changes in it.]
• [Prognosis and molecular pathogenesis of adult T-cell leukemia/lymphoma]